
Delgocitinib (Anzupgo) Scores FDA Approval for Chronic Hand Eczema
The US Food and Drug Administration (FDA) has approved delgocitinib (Anzupgo) cream for the treatment of moderate-to-severe chronic hand eczema. Announced by LEO Pharma on July 23, 2025, the approval indicates delgocitinib cream for the topical treatment …